Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 177

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

A protective effect of L actobacillus rhamnosus HN 001 against eczema in the first 2 years of life persists to age 4 years

Wickens, K., Black, P., Stanley, T. V., Mitchell, E., Barthow, C., Fitzharris, P., Purdie, G., Crane, J.·2012·Clinical & Experimental Allergy

Abstract

Summary: Background: Using a double blind randomized placebo‐controlled trial ( A ustralian N ew Z ealand C linical T rials R egistry: ACTRN 12607000518460), we have shown that in a high risk birth cohort, maternal supplementation from 35 weeks gestation until 6 months if breastfeeding and infant supplementation until 2 years with Lactobacillus rhamnosus HN 001 ( HN 001) (6 × 10 9 cfu/day) halved the cumulative prevalence of eczema by age 2 years. Bifidobacterium animalis subsp lactis HN 019 ( HN 019) (9 × 10 9 cfu/day) had no effect. Objective: The aim of this study was to investigate the associations of HN 001 and HN 019 with allergic disease and atopic sensitization among these children at age 4 years, 2 years after stopping probiotic supplementation. Methods: The presence ( UK W orking P arty's D iagnostic C riteria) and severity SCOR ing A topic D ermatitis ( SCORAD ) of eczema and atopy (skin prick tests) and parent‐reported symptoms of asthma and rhinoconjunctivitis were assessed using standard protocols and questions. Results: Four‐hundred and seventy‐four infants were eligible at birth of whom 425 (90%) participated in this follow‐up. The cumulative prevalence of eczema by 4 years (Hazard ratio ( HR ) 0.57 (95% CI 0.39–0.83)) and prevalence of rhinoconjunctivitis at 4 years (Relative risk 0.38 (95% CI 0.18–0.83)) were significantly reduced in the children taking HN 001; there were also nonsignificant reductions in the cumulative prevalence of SCORAD ≥ 10 ( HR 0.74 (95% CI 0.52–1.05), wheeze ( HR 0.79 (95% CI 0.59–1.07)) and atopic sensitization ( HR = 0.72 (95% CI 0.48–1.06)). HN 019 did not affect the prevalence of any outcome. Conclusions and Clinical Relevance: This study showed that the protective effect of HN 001 against eczema, when given for the first 2 years of life only, extended to at least 4 years of age. This, together with our findings for a protective effect against rhinoconjunctivitis, suggests that this probiotic might be an appropriate preventative intervention for high risk infants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2222.2012.03975.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 177

Metadata

Authors
Wickens, K., Black, P., Stanley, T. V., Mitchell, E., Barthow, C., Fitzharris, P., Purdie, G., & Crane, J.
Venue
Clinical & Experimental Allergy
Publisher
Wiley
Published
2012-06-15
Volume
42
Issue
7
Pages
1071-1079
ISSN
  • 0954-7894 (ISSN-L)
  • 1365-2222
OpenAlex
W2168304627
Cited by
177
References
2
FWCI
29.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A protective effect of L actobacillus rhamnosus HN 001 against eczema in the first 2 years of life persists to age 4 years. https://app.cochat.ai/papers/10.1111/j.1365-2222.2012.03975.x
The paper
Wickens, K., Black, P., Stanley, T. V., Mitchell, E., Barthow, C., Fitzharris, P., Purdie, G., & Crane, J. (2012). A protective effect of L actobacillus rhamnosus HN 001 against eczema in the first 2 years of life persists to age 4 years. Clinical & Experimental Allergy. https://doi.org/10.1111/j.1365-2222.2012.03975.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.